MilliporeSigma
All Photos(1)

Documents

14380C

SAFC

EX-CELL® CD Insect Cell Medium

Chemically defined, sterile-filtered, suitable (forinsect cell culture)

Sign Into View Organizational & Contract Pricing

Quality Level

sterility

sterile-filtered

form

liquid

technique(s)

cell culture | insect: suitable

components

NaHCO3: no
L-glutamine: yes

shipped in

ambient

storage temp.

2-8°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
14420C24381C14385C
EX-CELL® CD Insect Cell Medium Chemically defined, powder, suitable (for insect cell culture)

24381C

EX-CELL® CD Insect Cell Medium

form

liquid

form

liquid

form

dry powder

form

liquid

technique(s)

cell culture | insect: suitable

technique(s)

cell culture | insect: suitable

technique(s)

cell culture | insect: suitable

technique(s)

cell culture | mammalian: suitable (suspension)

components

NaHCO3: no
L-glutamine: yes

components

HEPES: no
L-glutamine: yes
glucose: yes
NaHCO3: yes

components

L-glutamine: yes

components

L-glutamine: no

shipped in

ambient

shipped in

ambient

shipped in

ambient

shipped in

wet ice

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

General description

EX-CELL® CD Insect Cell Medium can be used as amplification and production medium for Spodoptera frugiperda (Sf) cells such as Sf21 and Sf9 cells and is compatible with Tni, C636 and S2 cells. The medium has been optimized to get excellent growth and productivity for the rhabdovirus-free Sf-RVN Insect Cell Line(Sf9). Together those products form the Sf-RVN Platform. The formulation is chemically defined, animal-component free and has been formulated with L-Glutamine.

Legal Information

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany
Sf-RVN is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Product numbers are combined with Pack Sizes/Quantity when displayed on the website (example: T1503-25G). Please make sure you enter ONLY the product number in the Product Number field (example: T1503).

Example:

T1503
Product Number
-
25G
Pack Size/Quantity

Additional examples:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

enter as 1.000309185)

Having trouble? Feel free to contact Technical Service for assistance.

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Aldrich Products

  • For a lot number such as TO09019TO, enter it as 09019TO (without the first two letters 'TO').

  • For a lot number with a filling-code such as 05427ES-021, enter it as 05427ES (without the filling-code '-021').

  • For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'.

Not Finding What You Are Looking For?

In some cases, a COA may not be available online. If your search was unable to find the COA you can request one.

Request COA

Customers Also Viewed

Slide 1 of 2

1 of 2

Articles

Optimizing the upstream portion of gene therapy production sets the stage for successful manufacturing by maximizing viral vector titers. To increase upstream titers and process productivity, manufacturers must partner with upstream technology experts who work with HEK293, HEK293T and Sf9 cells. Draw on our experience today to speed your gene therapy to patients.

This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.

Related Content

The new Sf-RVN® Platform provides a high performant rhabdovirus-free alternative to produce recombinant proteins, virus-like particles (VLP) for viral vaccines, and adeno-associated viruses (AAV) to treat genetic diseases, improving the safety profile of your gene therapy and vaccines.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service